Sarepta Therapeutics
SRPT
SRPT
373 hedge funds and large institutions have $9.25B invested in Sarepta Therapeutics in 2022 Q3 according to their latest regulatory filings, with 81 funds opening new positions, 122 increasing their positions, 112 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
12.89% more ownership
Funds ownership: 83.81% → 96.71% (+13%)
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
9% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 112
Holders
373
Holding in Top 10
10
Calls
$269M
Puts
$160M
Top Buyers
| 1 | +$633M | |
| 2 | +$105M | |
| 3 | +$97.6M | |
| 4 |
Two Sigma Investments
New York
|
+$83.9M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$81.8M |
Top Sellers
| 1 | -$136M | |
| 2 | -$52.1M | |
| 3 | -$47.5M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$42.4M |
| 5 |
State Street
Boston,
Massachusetts
|
-$42.2M |